Calamos Advisors’s Exascale Labs Holdings Inc. Warrant XLABW Stock Holding History

Calamos Advisors’s Portfolio XLABW Stock Details XLABW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.8K	Buy	+98,703	New	+$29.5K	﹤0.01%	990

Other funds holding XLABW

PEAK6 Chicago, Illinois $54.8B AUM 16.89% 1-Year Est. Return

OMERS Administration Corp Toronto, Ontario, Canada $16.3B AUM 28.35% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

DLD Asset Management New York $1.44B AUM 3.08% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Calamos Advisors's XLABW Position: Q3 2026 in Review

Calamos Advisors opened a new position in Exascale Labs Holdings Inc. Warrant (XLABW) in Q3 2026: 98,703 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #990 among its holdings.

14 funds tracked by Wall St. Rank hold XLABW as of Q3 2026.

Calamos Advisors held 98,703 shares of Exascale Labs Holdings Inc. Warrant worth $15.8K as of Q3 2026.
Exascale Labs Holdings Inc. Warrant was a new Calamos Advisors position in Q3 2026.
Exascale Labs Holdings Inc. Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q3 2026, its #990 holding.
14 funds tracked by Wall St. Rank held Exascale Labs Holdings Inc. Warrant as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.